Impact Biomedical (IBO) EBITDA (2022 - 2026)
Impact Biomedical's EBITDA was -$364,000 in Q3 2026, compared with -$660,000 a year earlier.
Analysis
Impact Biomedical (IBO) EBITDA (2022 - 2026) Analysis & Trends
On a trailing twelve-month basis, Impact Biomedical's EBITDA was -$3.67 million through Sep 30, 2026; for FY2025, it came in at -$3.14 million.
- In earlier years, EBITDA was -$27.63 million in FY2024, -$2.91 million in FY2023 and -$2.29 million in FY2022.
- The Q3 2026 figure marks the highest quarterly EBITDA since Q2 2024.
- Per Business Quant data, IBO's EBITDA in the three quarters before Q3 2026 was -$418,000 (Q2 2026), -$2 million (Q1 2026) and -$884,000 (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn | 8.30 Bn |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn | 8.16 Bn |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn | 7.34 Bn |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - | - |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn | 5.99 Bn |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn | 4.83 Bn |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn | 4.20 Bn |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn | 7.05 Bn |
| 10 | Impact Biomedical | 43.92 Mn | 47.11 Mn | 15,000.00 | -364,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -364,000.00 |
| Jun 30, 2026 | -418,000.00 |
| Mar 31, 2026 | -2.00 Mn |
| Dec 31, 2025 | -884,000.00 |
| Sep 30, 2025 | -660,000.00 |
| Jun 30, 2025 | -865,000.00 |
| Mar 31, 2025 | -727,000.00 |
| Dec 31, 2024 | -25.95 Mn |
| Sep 30, 2024 | -846,000.00 |
| Jun 30, 2024 | -347,000.00 |
| Mar 31, 2024 | -491,000.00 |
| Dec 31, 2023 | -859,000.00 |
| Sep 30, 2023 | -798,000.00 |
| Jun 30, 2023 | -728,000.00 |
| Mar 31, 2023 | -523,000.00 |
| Dec 31, 2022 | -754,000.00 |
| Sep 30, 2022 | -610,000.00 |
| Jun 30, 2022 | -472,000.00 |
API Access
Impact Biomedical EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=IBO&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "IBO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=IBO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();